Montai Health
Adam Raff, M.D., Ph.D. currently serves as Vice President and Head of Translational Medicine at Montai Therapeutics. Previously, Adam has held positions at Beth Israel Deaconess Medical Center as a Dermatologist and at Harvard Medical School as an Instructor. Adam also worked at EQRx, where roles included Vice President of Immunology and Senior Medical Director. Furthermore, Adam was Director of Translational Medicine at LEO Pharma. Adam Raff's education includes training at Harvard Medical School - Massachusetts General Hospital from 2015 to 2017 and studies at Harvard University from 2013 to 2016.
This person is not in any teams
This person is not in any offices
Montai Health
Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health outcomes for as many people as possible. To address this crucial global concern, the business is pioneering cutting-edge technology to develop AnthromoleculeTM medications, which are derived from a privileged class ofcompounds with a history of safe human use. Our human-centered foundation can enable the rapid and repeatable development of safe, efficacious, and accessible medicines for as many diseases and people as possible by creating the world's first Anthromolecule Bioactivity Atlas, which comprehensively maps potent connections to all known biological pathways underlying disease.